Huafon Group Co., Ltd. acquired Biomaterials business from DuPont de Nemours, Inc. (NYSE:DD) on June 1, 2022.
Huafon Group Co., Ltd. acquired Biomaterials business from DuPont de Nemours, Inc. (NYSE:DD) on May 31, 2022. For full year 2021, the Biomaterials business unit recorded net sales of approximately $200 million. Moelis & Company LLC acted as exclusive financial adviser to Huafon Group Co., Ltd. in the transaction.